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Inorganic pyrophosphatases (PPases) are essential enzymes for every living cell. 
PPases provide the necessary thermodynamic pull for many biosynthetic reactions by 
hydrolyzing pyrophosphate. There are two types of PPases: integral membrane-bound 
and soluble enzymes. The latter type is divided into two non-homologous protein 
families, I and II. Family I PPases are present in all kingdoms of life, whereas family II 
PPases are only found in prokaryotes, including archae.  
Family I PPases, particularly that from Saccharomyces cerevisiae, are among the 
most extensively characterized phosphoryl transfer enzymes. In the present study, we 
have solved the structures of wild-type and seven active site variants of S. cerevisiae 
PPase bound to its natural metal cofactor, magnesium ion. These structures have 
facilitated derivation of the complete enzyme reaction scheme for PPase, fulfilling 
structures of all the reaction intermediates. 
The main focus in this study was on a novel subfamily of family II PPases (CBS-
PPase) containing a large insert formed by two CBS domains and a DRTGG domain 
within the catalytic domain. The CBS domain (named after cystathionine β-synthase in 
which it was initially identified) usually occurs as tandem pairs with two or four copies 
in many proteins in all kingdoms of life. The structure formed by a pair of CBS domains 
is also known as a Bateman domain. CBS domains function as regulatory units, with 
adenylate ligands as the main effectors. The DRTGG domain (designated based on its 
most conserved residues) occurs less frequently and only in prokaryotes. Often, the 
domain co-exists with CBS domains, but its function remains unknown. 
The key objective of the current study was to explore the structural rearrangements 
in the CBS domains induced by regulatory adenylate ligands and their functional 
consequences. Two CBS-PPases were investigated, one from Clostridium perfringens 
(cpCBS-PPase) containing both CBS and DRTGG domains in its regulatory region and 
the other from Moorella thermoacetica (mtCBS-PPase) lacking the DRTGG domain. 
We additionally constructed a separate regulatory region of cpCBS-PPase (cpCBS). 
Both full-length enzymes and cpCBS formed homodimers. Two structures of the 
regulatory region of cpCBS-PPase complexed with the inhibitor, AMP, and activator, 
diadenosine tetraphosphate, were solved. The structures were significantly different, 
providing information on the structural pathway from bound adenylates to the interface 
between the regulatory and catalytic parts. To our knowledge, these are the first 
reported structures of a regulated CBS enzyme, which reveal large conformational 
changes upon regulator binding. The activator-bound structure was more open, 
consistent with the different thermostabilities of the activator- and inhibitor-bound 
forms of cpCBS-PPase. 
The results of the functional studies on wild-type and variant CBS-PPases provide 
support for inferences made on the basis of structural analyses. Moreover, these 
findings indicate that CBS-PPase activity is highly sensitive to adenine nucleotide 
distribution between AMP, ADP and ATP, and hence to the energy level of the cell. 
CBS-PPase activity is markedly inhibited at low energy levels, allowing PPi energy to 





ADP Adenosine diphosphate 
AMP Adenosine monophosphate 
AMPK Adenosine monophosphate-activated protein kinase 
 rAMPKγ1 Type 1 gamma domain of Rattus norvegicus AMPK  
 mAMPKγ1 mammalian (here human or rat) AMPKγ1 
 spAMPK Schizosaccharocyces pombe AMPK 
AMPPNP  Adenosine 5′-(β,γ-imido)triphosphate  
AP4A  Diadenosine 5′, 5-P1, P4-tetraphosphate 
ATP Adenosine triphosphate 
CBS domain Domain named based on cystathionine β-synthase 
CBS dimer Dimer of CBS pair 
CBS pair Tight dimer of two CBS domains 
CBS-PPase CBS domain containing inorganic pyrophosphatase 
 cpCBS-PPase Clostridium perfringens CBS-PPase 
 mtCBS-PPase Moorella thermoacetica CBS-PPase 
ClC Chloride-conducting ion channel 
common family II PPase Non-regulated PPase family formed by DHH and DHHA2 
domains  
cpCBS  Regulatory part of cpCBS-PPase (residues 66–306) 
DHH Domain family, with DHH sequence 
DHHA2 DHH-associated domain found in PPases and 
exopolyphosphatases 
DRTGG domain Domain named based on conserved residues 
ESRF European synchrotron radiation facility 
HPrK/P  Histidine containing phosphor carrier protein kinase/ phosphatase 
IMPDH Inosine-5’-monophosphate dehydrogenase 
KEGG Kyoto Encyclopedia of Genes and Genomes 
MgtE Mg2+ transporter family 
MTA 5-methyl-5’-thioadenosine 
MurF  UDP-N-acetylmuramoyl-tripeptide D-Ala-D-Ala ligase  
NCS 2-fold non-crystallographic symmetry  
OpuA Glycine betaine transporter 
PDB Protein data bank  
Pi Inorganic phosphate 
P-loop Phosphate binding loop 
PNP Imidodiphosphate 
PPi Inorganic pyrophosphate 
PPase Inorganic pyrophosphatase 
scPPase Saccharomyces cerevisiae family I PPase 
ecPPase Escherichia coli family I PPase 
rmsd Root mean square deviation 
MRSAD Molecular replacement with single wavelength anomalous 
dispersion  
SAM S-adenosyl methionine 
SeMet  Selenomethionine  
TB  Terrific Broth  
ZMP Aminoimidazole 4-carboxamide ribonucleotide 
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Abbreviations for Amino Acids  
A Ala Alanine 
C Cys Cysteine 
D Asp Aspartic acid 
E Glu Glutamic acid 
F Phe Phenylalanine 
G Gly Glycine 
H His Histidine 
I  Ile Isoleucine 
K Lys Lysine 
L Leu Leucine 
M Met Methionine 
N Asn Asparagine 
P Pro Proline 
Q Gln Glutamine 
R Arg Arginine 
S Ser Serine 
T Thr Threonine 
V Val Valine 
W Trp Tryptophan  
Y  Tyr Tyrosine 
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1 Review of the Literature  
1.1 Inorganic pyrophosphatases 
Inorganic pyrophosphatases (PPases, EC 3.6.1.1) catalyze hydrolysis of the 
pyrophosphate, one of the simplest phosphoryl transfer reactions. Inorganic 
pyrophosphate (PPi) is produced in vast amounts from nucleoside triphosphates in vital 
biosynthetic reactions, such as protein, RNA and DNA synthesis, and hydrolysis of PPi 
by PPase provides the necessary thermodynamic pull for these reactions, making this 
enzyme essential for life [1-5]. PPi additionally regulates many other cellular 
processes, including calcification, cell proliferation and iron transport [6]. 
Consequently, disruption of PPi metabolism can lead to a variety of pathological 
conditions [6].  
Two types of PPases have been identified: integral membrane-bound and soluble 
enzymes. Integral membrane-bound ion-translocating inorganic pyrophosphatases 
pump H+ [7] or Na+ ions [8] across biological membranes using energy released upon 
PPi hydrolysis. In certain situations, proton pumps can work as PPi synthases [9]. 
Soluble PPases are divided into two well-characterized non-homologous families, 
designated I and II [10, 11], which are described below in more detail. 
1.1.1 Family I PPases 
Family I PPases, the most common pyrophosphatases found in all kingdoms of life, are 
among the most extensively characterized phosphoryl transfer enzymes [12, 13]. These 
enzymes act mainly constitutively without regulation. The only exception found so far 
is phosphorylation-inhibited plant pollen tube PPase [14]. Within this family, 
eukaryotic Saccharomyces cerevisiae PPase (scPPase) and the bacterial enzyme from 
Escherichia coli (ecPPase) are the most widely studied.  
The X-ray structures of several family I PPases have been solved during the last 
few decades. scPPase was initially crystallized in 1974 [15], and the first apo-scPPase 
structure published in 1981 [16]. Ten years later, the structure of the first scPPase 
product complex was solved [17], but phosphate was misplaced, which was corrected 
after five years [18, 19]. The first ecPPase structures were obtained in 1994 [20, 21]. 
Subsequently, several ecPPase and scPPase structures were solved with and without 
different ligands [22-25], some to very high resolution (ecPPase to 1.05 Å [26] and 
scPPase to 1.15 Å [27]), along with those of several variants [26, 28, 29]. The 
structures of family I PPase from Thermus thermophilus [30], Sulfolobus 
acidocaldarius [31], Pyrococcus horikoshii [32] and Mycobacterium tuberculosis [33] 
have additionally been determined. In addition, the PPase structures from five other 
species (Anaplasma phagocytophilum, Ehrlichia chaffeensis, Burkholderia 
pseudomallei, Brucella melitensis and Rickettsia prowazekii) (PDB ID: 3LD3, 3LO0, 
3GVF, 3FQ3 and 3EMJ, respectively) obtained in the latest structural genomics project 
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at Seattle Structural Genomics Center for Infectious Disease have been submitted to 
protein data bank (PDB). 
The overall fold of family I PPases is a highly twisted five-stranded β-barrel with 
some α-helical and β-strand extensions. Family I PPases display a simple cup-like 
single domain structure where the active site is located at the bottom of the cup (Figure 
1). Although shorter bacterial E. coli PPase only contains 175 residues and displays 
28% sequence identity with the 286-residue eukaryotic scPPase [13], the structural 
cores of the two enzymes are very similar, with the root mean square deviation of 158 
Cα atoms of only 1.45 Å [19]. Active sites are highly conserved.  However, the 
oligomeric structures differ between bacterial and eukaryotic family I PPases, in that 
the former forms a dimer of trimers while the latter is homodimeric. 
 
Figure 1. View from top to bottom of the cup (dark gray surface on cartoon) of scPPase (PDB 
ID: 1E6A). In the fluoride-inhibited structure, F- (black ball) occupies the position of 
nucleophilic water, Mn2+ ions are presented as white balls, and the substrate as a stick model. 
One monomer of the dimeric protein is visualized as a cartoon, and the other as a space-filling 
model.  
PPases are metal-dependent enzymes that use divalent activation cations (Mg2+, 
Zn2+, Mn2+ and Co2+). Ca2+ is a competitive inhibitor [34]. Mg2+, which binds with 
micromolar affinity, confers high substrate specificity for inorganic pyrophosphate 
[35], the only physiologically relevant substrate. PPase catalysis requires three or four 
metal ions per substrate molecule [36], depending on the pH and PPi concentration. In 
yeast cells, the PPi concentration and pH favor the three-metal ion mechanism [36], 
whereas at the low pH used for crystallization, the four-metal mechanism 
predominates. Hydrolysis of the metal-complexed pyrophosphate is accelerated by a 
factor of 1010, compared to the uncatalyzed reaction [37]. 
Review of the Literature 
 
11 
The catalytic reaction of these enzymes is well-characterized. The effects of all 
eighteen charged and tyrosine residues in identical ecPPase and scPPase active sites 
have been studied via conservative site-directed mutagenesis [38]. Kinetic analyses 
have disclosed six separate reaction steps, as shown in Scheme 1. The enzyme is 
activated by two metal ions (Scheme 1, A), and one or two additional metal ions 
interact with the substrate (Scheme 1, B). The metal positions in the active site are 
termed M1−M4 in the proposed order of metal binding, where M1 and M2 are the 
activating metal ions, and M3 and M4 bind with substrate [19]. The enzyme undergoes 
isomerization (Scheme 1, B → C), as evident from both enzymological [39, 40] and 
structural data [27]. The generation of the reactive nucleophile, ONu, between M1 and 
M2 is aided by a low-barrier hydrogen bond between D117 and the nucleophile [27]. 
The protonation state of the nucleophile has not been directly observed, and is 
therefore denoted ONu. After the hydrolysis step (Scheme 1, D), the two 
phosphate−metal complexes are individually released (Scheme 1, E and F), and the 
enzyme returns to the two metal ion form (Scheme 1, A).  
 
Scheme 1. Six-state mechanism of scPPase. (paper I) 
The rate-determining step for the forward reaction with Mg2+ as the cofactor is PPi  
hydrolysis (Scheme 1, C → D), whereas in the reverse direction leading to net 
synthesis, the rate-determining step is the preceding isomerization step (Scheme 1, C 
→ B) [41]. Isomerization decreases the pKa of the nucleophile to 5.85 [40], which is 
structurally explained by the two-water bridge collapsing into a single nucleophilic 
water between the M1 and M2 metal ions.  
In the earlier scPPase structures, the complexed metal ions were the less active 
cofactors, Mn2+ [19, 27] or Co2+ (PDB ID: 1M38 [42]), both of which bind phosphate 
with higher affinity [43]. The identity of the metal cofactor determines the order of 
phosphate release [44, 45], so that the leaving group phosphate, P2, is released before 
the electrophilic phosphate, P1, after PPi hydrolysis in the presence of Mg
2+. This order 
is reversed with Mn2+ as the cofactor [46].  
Intermediates A and C−E in the proposed kinetic scheme (Scheme 1) have been 
described earlier [27]. The scPPase·Mn2 structure at 2.2 Å resolution (PDB ID: 1WGI 
[19]) represents intermediate A, where the metal sites, M1 and M2, are filled. The 
fluoride-inhibited product complex at 1.9 Å (PDB ID: 1E6A [27]) representing 
intermediate C contains four metal ions, PPi, and a fluoride ion replacing the 
nucleophilic ONu (Figure 1). The product complex at 1.15 Å resolution (PDB ID: 1E9G 
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[27]) contains two conformations of the hydrolyzed product, which correspond to 
intermediates D and E, where the latter is a hydrated rearrangement of D. Structures of 
the intermediates B and F are yet to be solved. 
1.1.2 Family II PPases 
Family II PPases, also designated type C PPases [47, 48], were discovered more 
recently in 1998 [10, 11]. These enzymes exist almost exclusively in Bacteria, mainly 
in Firmicutes (Table 1), including several human pathogens. Most of family II PPases 
(common family II PPases) are composed of two well-defined domains, N-terminal 
DHH and C-terminal DHHA2, and belong to the DHH (Asp-His-His) family of 
phosphohydrolases (Figure 1 in original publication III) [49]. One-quarter of family II 
PPase enzymes contain a 250-residue insert within the N-terminal domain. The insert 
(regulatory region) consists of a DRTGG domain between two CBS domains (both 
type of domains are descriped more details later). These “longer” PPases are denoted 
CBS-PPases to distinguish them from common family II PPases. The DRTGG domain 
is missing in Moorella thermoacetica, Syntrophomonas wolfei and Syntrophothermus 
lipocalidus CBS-PPases (Table 1).  
Several structures of common family II PPases are available. Initially, the structures 
were solved in 2001 from Streptococcus mutans (PDB ID: 1I74) [50], Streptococcus 
gordonii (PDB ID: 1K20) [48] and Bacillus subtilis (PDB ID: 1K23) [48] enzymes 
with variable domain interface conformations and different Mn2+ and sulfate 
combinations. Subsequently, product analog complexes were solved, including S. 
gordonii PPase complexed with sulfate and Zn2+ (PDB ID: 1WPP) [51] and metal-free 
B. subtilis PPase complexed with high-affinity sulfate (PDB ID: 1WPN) [51]. 
Substrate analog complexes include imidodiphosphate (PNP) complexes of 
Streptococcus agalactiae PPase with two Mn2+ and a Mg2+ (PDB ID: 2ENX) [52], 
fluoride-inhibited B. subtilis PPase with Mg2+ (Figure 2) [53] and B. subtilis H98Q 
variant PPase with two Mn2+/Fe2+ and two Mg2+ ions (PDB ID: 2IW4) [53]. 
Family II PPases are homodimeric (Figure 2), similar to the eukaryotic family I 
PPase. A flexible linker connects the N- and C-terminal domains, with the active site 
located at the domain interface [48, 50]. The C-terminal domain of family II PPase 
contains the high-affinity substrate-binding site, whereas the catalytic site that binds 
the nucleophile-coordinating metal cations is located in the N-terminal domain. 
Closure of the C-terminal domain onto the N-terminal region creates a catalytically 
competent conformation by bringing the electrophilic phosphate of substrate into the 
catalytic site [51]. Substrate binding to the C-terminal domain in the open 
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Figure 2. Dimeric common family II PPase formed by N-terminal DHH (light gray) and C-
terminal DHHA2 (dark gray) domains (PDB ID: 2HAW); otherwise coloring is similar to that 
in Figure 1. The active site is located between two flexible domains and occupied with F-, Mg2+ 
and the substrate analogy PNP. 
Both soluble PPase families catalyze the same PPi hydrolysis reaction, and have 
similar active sites [48, 50] but significantly different functional properties. Unlike 
family I PPases, family II enzymes are most effectively activated by Mn2+ or Co2+, 
which bind with nanomolar affinity [54]. Family II PPases with these metal ions as 
cofactors are about 10-fold more active than family I PPases with Mg2+ (kcat of 1700-
3300 s-1 versus 110-330 s-1) [47, 54, 55]. In addition, divalent cations, in particular, 
Mn2+, promote enzyme dimerization, where the dimer is the active form of family II 
PPase [54]. 
The crystal structures revealed that the preference for Mn2+ over Mg2+ in family II 
PPases is at least partly attributable to the active site histidines that bind the metal ions 
and bidentate carboxylate coordination of the metal ion in the binding site [50]. 
Substrate binding to family II PPase appears to require a change in the coordination 
number of the high-affinity metal site from five to six [51]. Varied five/six-coordinated 
geometry is typical for transition metals, such as Mn2+ or Co2+, but not Mg2+, which is 
almost always six-coordinated [57]. Consequently Mn2+ and Co2+ fit the catalytic 
machinery better than Mg2+. Furthermore, Zn2+, which does not form the six-
coordination complex easily [57], is a very poor activator of family II PPase [51, 55].  
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Most highly active common family II PPases appear to be constitutively active, but 
pathogenic Streptococcus agalactiae and Streptococcus pneumonia common family II 
PPases are regulated via kinase-dependent phosphorylation [58, 59]. Disruption of 
kinase or phosphatase function affects cell growth, segregation and virulence in S. 
agalactiae [58]. Other homologous pathogenic bacterial species, such as Streptococci, 
Staphylococci and Enterococci, may be similarly regulated [58]. In S. agalactiae 
family II PPase, four potential phosphorylation sites have been identified in the dimer 
interface area [52], but further studies are needed for distinguish the actual 
phosphorylation site. 
1.2 The CBS domain 
The CBS domain (Pfam: PF00571 [60]) is a small intracellular region usually present 
in proteins as a tandem pair with two (or less frequently, four) copies. Two CBS 
domains form a CBS pair or Bateman domain, designated based on Alexander 
Bateman, who was the first to identify this structure while studying genome internal 
duplications in Methanocaldococcus jannaschii in 1997 [61]. He also named this 
cystathionine β-synthase-like domain 'CBS domain' [62].  
1.2.1 Proteins with the CBS domain 
According to the Pfam database [60], CBS domains have been identified in nearly 
30 000 protein sequences of numerous cytosolic and membrane-associated enzymes 
and channels from all kind of species [63]. Typically, orthologous proteins in some 
species do not contain the CBS pair whereas others have it, indicating that this 
structure is not essential for protein function [64-66]. The most extensive research to 
date has been performed on the CBS domain-linked human hereditary disease-causing 
proteins, AMP-activated protein kinase (AMPK), chloride-conducting ion channel 
(ClC), cystathionine β-synthase and inosine-5’-monophosphate dehydrogenase 
(IMPDH) [63]. The group of Martínez-Cruz is currently focusing on CBS domain-
containing proteins from M. jannaschii. This hyperthermophilic organism contains 15 
proteins with the CBS domain [67, 68]. More recent studies have investigated a Mg2+ 
transporter (MgtE) and glycine betaine ABC transporter (OpuA) [69, 70]. Several CBS 
domain-only protein structures with two or four CBS domain repeats have been solved, 
but their partners and physiological functions remain unknown [71-75]. The 
coordinates for many CBS domain structures have recently been deposited to the 
Protein Data Bank (PDB ID: 1PBJ, 1YAV, 1VR9, 2O16, 2P9M, 2EMQ, 2YZI, 2YZQ, 
3DDJ, 3FHM, 3K6E, 3LQN, 3FNA, 3LFR, 3LHH, 3LV9, 3FV6, 3FVR, 3FVS and 
3OCO), but no descriptions have been published.  
CBS domains are widely distributed among proteins with distinct functions. The 
most extensively studied CBS domain-containing proteins are presented below. 
Cystathionine β-synthase is a homotetrameric protein with the regulatory heme domain 
located at the N-terminus, catalytic part in the middle, and CBS pair at the C-terminus 
[76]. AMPK is a heterotrimeric protein consisting of α, β and γ subunits, whereby the γ 
subunit contains a tetra repeat of CBS domains [77]. Mammals have three paralogous γ 
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subunits (AMPK γ1-3), of which AMPKγ1 is the shortest and contains only CBS 
domains.  
ClCs are homodimeric integral membrane proteins with a CBS domain pair in the 
cytoplasmic C-terminal region. ClC-0 from the electric organ of the electric ray, 
Torpedo marmorata, was initially identified and cloned [78], followed by nine 
paralogous mammalian ClCs (ClC-1 to ClC-7, ClC-Ka and ClC-Kb), which vary in 
terms of length of the cytoplasmic C-terminal region (residues 155 to 398). 
Mammalian ClC channels exhibit differential tissue localization [66]. ClC-0, ClC-1, 
ClC-2, ClC-Ka, and ClC-Kb share about 50–60% sequence identity. These proteins are 
located on the cell membrane and denoted 'muscle-type ClCs'. ClC-3 to ClC-5 form a 
second group, which are localized on the membranes of intracellular vesicles. The third 
subfamily comprises ClC-6 and ClC-7, which are broadly expressed in various tissues.  
Two paralogous IMPDHs exist in humans (hIMPDH1 and hIMPDH2). IMPDH is a 
homotetrameric protein in which the CBS pair is inserted within the catalytic sequence 
but located as a separate domain at the protein surface [79]. The typical homodimeric 
bacterial MgtE Mg2+ transporter consists of a cytosolic N-terminal part including the 
N-domain and a CBS pair, as well as a transmembrane C-terminal region [69]. OpuA is 
composed of two identical nucleotide-binding domains fused to the CBS pair and two 
identical substrate-binding domains fused to the transmembrane domain [80].  
1.2.2 Natural mutations in the CBS domain 
Point or deletion mutations in the CBS domains of human proteins (Figure 3) cause 
various hereditary diseases. Several natural mutations found in the CBS domain of 
human cystathionine β-synthase [81-83] trigger homocystinuria either through loss of 
enzyme activity (V456P mutation) [83] or regulatory function (D444N mutation) [81]. 
Amino acid substitutions (R224P or D226N) in the CBS domain of hIMPDH1 cause 
retinitis pigmentosa, a hereditary disease, which can lead to blindness [84, 85]. 
Mutations in ClCs are linked to several hereditary diseases, some of which are located 
in the CBS domains. Point mutations in ClC-Kβ cause Bartter syndrome [86], 
substitutions in ClC-7 lead to osteopetrosis [87-89] and several different-length C-
terminal truncations  in ClC-5 (shortest severe deletion after R648) trigger Dent disease 
[90, 91]. Point mutations in the CBS domain of AMPK are associated with two 
hereditary diseases, Wolff-Parkinson-White syndrome [92] and familial hypertrophic 
cardiomyopathy [93]. Furthermore, the R250Q substitution in Hampshire pig AMPK 
γ3 (pAMPK γ3) enhances the glycogen content in skeletal muscle about 70%, leading 
to deterioration of pork meat quality [94, 95]. Similar effect is observed in humans 
where equivalent mutation R225W of AMPK γ3 increased about 90% glycogen 
content in muscle cells of obese people [96]. 
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Figure 3. Sequence alignment of CBS domains 1 and 2 of proteins with disease-causing 
mutations. Disease-associated residues are shaded in gray. The C-terminal deletion is presented 
with a gray bar. CBS protein designation (the h prefix indicates human protein): hCBS, human 
cystathionine β-synthase; pAMPK γ3, pig AMPK γ3. For AMPKs containing two pairs of CBS 
domains per subunit, CBS domain numbers are presented after protein names. Sequence 
extensions are indicated as the number of residues in parentheses. Sequence numbering is 
shown on the right. Core CBS domain secondary structures based on hCLC-5 are presented 
above alignments. Ribose phosphate binding motifs are highlighted in boxes. 
1.2.3 Structures of CBS domain proteins 
CBS domains about 60 residues in length from various proteins and organisms have 
low sequence conservation within protein families, but display conserved three-
dimensional structures [97]. CBS domains fold into an / structure with internal 
symmetry [71]. These form a typical core β-α-β-β-α fold [62], along with an additional 
small helix and often, a short β-sheet at the N-terminal region of the domain (Figure 
4a) located adjacent to the neighboring CBS domain (Figure 4b) [73]. The CBS pair is 
a tight structure, since these domains complement each other, even when expressed 
separately [98] and from different proteins [99]. 




Figure 4. Topology of the CBS domain. (a) CBS domain core is presented in gray and the 
common CBS linker in white. The figure has been generated with TopDraw [100]. (b) A CBS 
domain is colored and labeled as (a) and pairing CBS domain with black. Labels for pairing 
CBS domain include prime. The β-Strands (β1-3) form a β-sheet and β0 is part of the pairing 
CBS domain β-sheet beside on β3´ (PDB ID: 2RIF). 
Several X-ray structures of CBS domains have been solved. The first structure was 
that of intact IMPDH from Streptococcus pyogenes, which was determined before 
identification of the CBS domain ligands [79]. Catalytic domains of the 
homotetrameric enzyme form intermolecular interactions and CBS domains form a pair 
that is a separate flexible structure on the protein surface. Thereafter, several structures 
of separate regulatory CBS domains or functional parts of proteins have been 
determined. For instance, the structure of human cystathionine β-synthase was solved 
without CBS domains, since the full-length protein has a tendency to aggregate [101]. 
The protein is dimeric in this structure, and it is speculated that its CBS pair is 
responsible for tetramerization of full-length protein in solution [102]. 
The structure of full-length ClC from E. coli has been solved. Interestingly, this 
transporter does not contain CBS domains in the cytoplasmic region, unlike human 
ClCs [103]. In addition, three structures of ClC CBS pairs have been determined, 
specifically, ClC-0 [104], ClC-5 [105] and ClC-Kα [106]. The CBS pair of ClC-5 
dimerizes via β1-strand interactions to form a V-shaped oligomeric structure, which 
brings two CBS2 domains into close proximity to each other, with few interactions 
between the remote CBS1 counterparts (Figure 5a). This observation was confirmed in 
solution studies and is thus not a crystallization artifact [105]. ClC-Kα dimerizes 
similar to ClC-5, and while ClC-0 crystal packing is different, mutagenesis studies 
have shown that dimerization in solution is similar to that of the other two ClCs [105].  
AMPKs are among the most intensively studied CBS domain-containing proteins 
with bound adenylate ligands. Several AMPK structures have been solved, but none 
determined for the full-length heterotrimeric protein. Separate domain structures have 
been established for α [107] and β subunits [108], as well as a fragment of the γ1 
subunit comprising the CBS3 and CBS4 domains [109, 110]. Moreover, core structures 
including the γ1 subunit and closely related parts of α and β subunits have been solved 
[111-113]. The CBS pairs of the AMPK γ1 subunit dimerize differently, compared 
with ClCs, and form an elliptical disk-like structure (Figure 5b) about  60 Å in 
diameter and 30 Å thick, which contacts helices α1 and α2 of CBS domains [112]. In 
Review of the Literature 
 
19 
both CBS3-4 pair structures, the CBS3 domain interacts with the CBS4 domain from 
the other monomer, and vice versa (head-to-tail assembly) [109, 110]. Full-length γ1 
subunit with a CBS domain tetra repeat forms a similar disk-like dimer, but displays 
head-to-head assembly in which CBS1 interacts with CBS3 and CBS2 with CBS4, 
which appears to be a biological unit in solution [111-113].  
 
Figure 5. Dimerization patterns of the CBS pair in ClC-5 (PDB ID: 2JA3) (a) and tetra-repeat 
AMPK γ1 (PDB ID: 2OOX) (b) are different. In the ClC dimer, CBS2 domains are adjacent to 
each other, whereas in AMPK and most other proteins, CBS pairs dimerize by forming a disc-
like assembly.  
Structures of several CBS domain-only proteins have been solved, but their 
functions and possible partner proteins remain unknown at present. The first structure 
was obtained for Thermotoga maritima TM0935 protein (PDB ID: 1O50) [71]. An in 
situ proteolysis project yielded one Nitrosomonas europaea CBS domain-only 
structure (NE2398) (PDB ID: 2RC3) in which 15 C-terminal residues were deleted 
[72]. The first archaea structure was obtained from hyperthermophilic Sulfolobus 
tokodaii (ST2348, PDB ID: 2EF7) [74]. CBS domain-only protein from 
Mycobacterium tuberculosis was designated 'hypoxic response protein 1' (HRP1, 
Rv2626c, PDB ID: 1XKF and 1Y5H), based on the observed 12- to 107-fold 
upregulation during hypoxia [75]. Bacterial Pyrobaculum aerophilum PAE2072 (PDB 
ID: 2RIH and 2RIF) [73] and M. jannaschii MJ1225 [68] have additionally been 
identified as CBS domain-only proteins. The common feature in all these proteins, with 
one exception (PDB ID: 1XKF), is the elliptical disk-like assembly, similar to the 
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AMPK γ subunit, which appears to be a typical assembly for CBS domains. 
Differences are evident in dimerization. Although all proteins, except TM0935, display 
head-to-head assembly, the dimer interface involves both CBS domains in TM0935, 
NE2398, PAE2072 and MJ1225 structures, whereas only CBS1 domains are involved 
in dimerization of HRP1 (PDB ID: 1Y5H) and CBS2 domains in ST2348. The 
biological relevance of these different contacts is yet to be established.  
In addition to bacterial IMPDH, proteins with known full-length structures include 
CBS-Zn ribbon-like protein from Thermoplasma acidophilum (TA0289) [97] and the 
membrane Mg2+ transporter, MgtE, from Thermus thermophilus [69]. The CBS pair of 
TA0289 appears to play a role in dimerization, whereas the CBS pair of MgtE works as 
a regulator. Both proteins display the dimeric disk-like assembly of CBS domains. 
1.2.4 Ligand binding to the CBS domain  
The first CBS domain ligand was identified when cystathionine β-synthase S-adenosyl 
methionine (SAM) activation was prevented upon deletion of the C-terminal CBS 
domains [102]. Subsequently, Hardie and Hawley [114] discovered that AMPK is 
activated by AMP and inhibited by ATP. In 2004, Scott and co-workers [115] 
demonstrated for the first time adenylate binding to separate CBS domains of human 
hereditary disease-associated proteins. The group showed that tetra repeats (CBS1-4) 
of AMPK γ1-3 interact with both AMP and ATP, but bind AMP more strongly. 
Moreover, the CBS pair of IMPDH2 bound ATP more strongly than AMP. Weak ATP 
binding was also observed with the CBS pair of ClC-2, and SAM bound to the CBS 
pair of cystathionine β-synthase. This was a breakthrough study in identifying CBS 
domain ligands. 
Ligand binding studies facilitated the determination of several adenylate-bound 
structures [67, 68, 72, 73, 105, 109, 111-113] (PDB ID: 3DDJ, 3FHM, 3FNA, 2YZQ, 
2FWR, 3FWS and 3LFR). The CBS domain ligands identified to date include AMP, 
ADP, ATP, NAD+, NADH, SAM and 5'-deoxy-5'-methylthioadenosine (MTA). 
Furthermore, some structures contain bound phosphate (PDB ID: 3K6E and 2O16), 
sulfate (PDB ID: 1YAV and 2RIH [73]) or a ligand analog (e.g., the ATP analog, 
adenosine 5′-(β,γ-imido)triphosphate (AMPPNP) or the AMP analog, aminoimidazole 
4-carboxamide ribonucleotide (ZMP)). 
Ligands bind to the cleft within the CBS pair. Each CBS pair has two potential 
ligand binding sites on both sides, which contain some conserved elements, for 
instance, a ribose phosphate-binding motif (CBS motif, Figure 3), Ghx(T/S)x(T/S)D 
(where h is a hydrophobic residue and x is any residue) [109], responsible for AMP 
binding. The hydrophobic residue (h) interacts with the adenine ring, both Thr/Ser 
residues bind phosphate, and aspartate binds ribose hydroxyls. The backbone atoms of 
the hydrophobic residue contact adenine N1 (-N) and N6 (-O). The pairing CBS 
domain provides the other hydrophobic residue to interact with the adenine ring. There 
is notable variation in the binding residues, which may explain the diversity of CBS 
domain ligands. 
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Typically, a CBS pair binds only one adenylate ligand on one side, as observed in 
the first adenylate-bound structures of the CBS pair from ClC-5 (Figure 6a) [105]. 
ADP and ATP bind to the same site, with the exception of AMPK γ, in which the CBS 
domain tetra repeat binds to all possible sites. Rattus norvegicus AMPK γ1 (rAMPK 
γ1) has one strong AMP binding site in the CBS4 domain, which maintains interactions 
with the ligand through the protein purification process. Bound AMP cannot be 
replaced by soaking with other adenylate nucleotides [112]. The same site binds the 
drug molecule, ZMP [109, 113]. Mammalian (human and rat) AMPK γ1 (mAMPK γ1) 
CBS1 and CBS3 motifs bind at least AMP and ATP, depending on ligand availability 
and concentration [109]. While ligand binding to the CBS2 motif in mAMPK γ1 has 
not been demonstrated, it is an ADP-specific site in Schizosaccharomyces pombe 
AMPK (spAMPK). 
1.2.5 Conformational changes induced by the CBS domain 
Several structures of different adenylate ligands bound to same site have been 
published, but do not reveal how the regulation signal is transmitted to the functional 
part of the protein. For example, only minor differences are observed between  ClC-5 
structures with different ligands (Figure 6a) [105]. No structures have been solved for 
the same protein with and without ligand. For the Pyrobaculum aerophilum CBS-
domain-containing protein, PAE2072, one structure has four AMPs, while the other 
contains four sulfates (Figure 6b) [73]. However, no significant conformational 
changes are evident between the two complexes.  
 
Figure 6. (a) ADP (light gray) and ATP (dark gray) bind similarly to the CBS pair in ClC-5 
(PDB ID: 2JA3 and 2J9L, respectively), with no evident conformational changes between the 
two complexes. (b) Minor movements are observed in the CBS domain-only protein PAE2072 
from Pyrobaculum aerophilum when sulfate is bound instead of AMP (PDB ID: 2RIH and 
2RIF, respectively). Binding residues are labeled, and presented as a ball-and-stick model. 
Significant conformational differences are observed in only the CBS pair of M. 
jannaschii MJ0100 protein structures bound to different adenylates. The function of 
this protein is still unknown. Interestingly, crystallization of the CBS pair of MJ0100 
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with no added ligands in different forms revealed structures containing different 
combinations of SAM and MTA, which induced distinct conformations. Based on the 
structures, it was hypothesized that SAM binds initially in such a way that the 
methionyl group of the ligand remains disordered and the dimer interface is 23° open 
(Figure 7). Subsequently, SAM adopts a more compact conformation, allowing a 
second SAM molecule to bind (interface 12° open). In the third structure, both SAM 
molecules are ordered (interface 9° open), facilitating the final binding of one or two 
MTA molecules and dimer closure (Figure 7). These binding steps do not significantly 
affect monomer assembly; maximal rmsd (root mean square deviation) of C with and 
without ligand is 0.88 Å [67].  
 
Figure 7. MJ0100 protein [67] in open (PDB ID: 3KPB, gray) and closed (PDB ID: 3KPD, 
black) conformations. In the conformation opened by 23, one SAM molecule is bound, 
whereas the closed conformation contains three ligands. Dimer interface helices are highlighted 
as cartoons. The arrow indicates CBS2 interface opening.  
Conformational changes were also observed in two other CBS domain-containing 
proteins in the absence of adenylate ligands. MgtE structures display conformational 
changes due to fluctuating Mg2+ concentrations, where the CBS2 domain interface 
opens/closes by 20 [69]. Movement was additionally observed in the other domain, 
which was rotated out by 120, but it is unclear how this change mediates protein 
function. Fluorescence resonance energy transfer measurements disclosed a significant 
movement in ClC-0 [116], although the regulator is yet to be identified.  
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1.2.6 Function of the CBS domain  
Functional studies on CBS domain-containing proteins have disclosed that they 
typically maintain their structure and function upon deletion of the CBS regions. 
Deletion of the CBS pair in IMPDH [117] and cystathionine β-synthase [76] did not 
affect catalytic activity. CBS domains only appear essential for function or cellular 
localization in CICs [118, 119].  
Several functions have been proposed for CBS domains. One obvious role is protein 
dimerization, which is evident in crystal structures. For instance, cystathionine β-
synthase is tetrameric in solution [76, 102], whereas the solved structure without CBS 
domains is dimeric [101], suggesting that CBS domains are fully responsible for 
tetramerization.  
A second possible function of the CBS pair is autoinhibition. Cystathionine β-
synthase [76] can be activated upon binding to SAM or deleting the C-terminal CBS 
domain-containing region [102]. Furthermore, the point mutations I435T, P422L and 
S466L in cystathionine β-synthase weaken autoinhibition, similar to R152Q and 
R171Q in rAMPK γ1 [120] and R225Q in pAMPK γ3 [95]. In contrast, hClC-1 ligand 
binding site variants (T636A, P638A, H847A and L848A) suppress protein function, 
similar to that observed upon ATP binding to wild-type [121].  
Sensing of adenylate ligands, i.e., energy level of cells, is a third and probably most 
important function of CBS domains. AMP-activating AMPK is most extensively 
characterized in this respect, and works as a whole human body energy balance sensor. 
When energy is consumed, the ATP level decreases and both AMP and ADP levels 
increase. Since adenylate kinase maintains a constant ATP:ADP ratio by catalyzing the 
reaction: 2ADP ⇔ ATP + AMP, the AMP concentration displays the largest variations 
during cell stress, and is therefore a more effective sensor molecule than ADP [114]. 
However, AMP is not used as an effector in all AMPKs, since lower eukaryotic S. 
cerevisiae AMPK (scAMPK) does not respond to AMP, but to lowered glucose levels 
via phosphorylation. Alkaline stress and increased ionic strength activate scAMPK 
[122].  
Adenylate sensing by the ClC family has been also studied intensively. While ClC-
4 is activated by ATP [123], ClC-1 [105, 121] and the plant ClC family member 
Arabidopsis thaliana nitrate/proton antiporter (AtClCa) [124] are inhibited by ATP. 
The role of the CBS domain has been confirmed with ATP binding studies on ClC-2 
[115], ligand-bound ClC-5 structures [105] and mutagenesis studies on ligand binding 
in AtClCa [124].  
Based on the observed scAMPK activation at increasing ion strength, it is proposed 
that ion sensing is a fourth function of the CBS domain. This function has been 
comprehensively investigated with the ABC transporter, OpuA. Lactococcus lactis 
OpuA is deactivated at low ionic strength and activated above a threshold ionic 
strength, and deletion of the CBS2 domain makes protein almost insensitive to ionic 
strength [125]. Mahmood and co-workers [70] showed that positively charged residues 
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in a loop between β2 and β3 (Figure 4) are essential for ionic strength sensing. MgtE is 
another ion-sensing CBS domain protein, responding to the Mg2+ level. The structure 
of Thermus thermophilus MgtE contains several Mg2+ ions, with one bound to the 
adenylate binding site of CBS domain whereby the CBS2 dimer interface is opened by 
20 and the other domain rotated by 120 in the absence of Mg2+ [69]. 
DNA and RNA binding is the fifth possible function of the CBS domain, in view of 
the finding that bacterial IMPDH binds 100 base-long single-stranded DNA and RNA 
in the nanomolar range in vivo [126]. However, there is no evidence of nucleic acid 
binding to the CBS domain. 
1.3 The DRTGG domain 
The DRTGG domain (Pfam: PF07085), designated based on its most conserved 
residues, consists of about 120 amino acids, and is often associated with CBS domains. 
Bateman speculated that this domain is very distantly related to the CBS domain pair. 
While there are no significant sequence similarities between these regions, its length 
and association with CBS domains supports this theory (Pfam database [60]). 
The protein data bank contains one separate DRTGG domain structure of a 
hypothetical protein from Archaeoglobus fulgidus (PDB ID: 2IOJ), but no data on this 
structure are currently available. Only two studies have focused on the DRTGG 
domain, both with phosphotransacetylase (Pta), which contains the DTRGG domain in 
a 350-residue N-terminal extension before the catalytic region. The results of one study 
showed that the DRTGG domain mutation, R252H, in the N-terminal region of 
Salmonella enterica Pta prevents NADH inhibition and enhances pyruvate activation, 
compared with wild-type, indicating that this region plays a role in NADH and 
pyruvate regulation. No evidence is available on where the two effectors bind  in the 
phosphotransacetylase N-terminal region [127]. Yet another study has shown that 
DTRGG domain truncations in the Escherichia coli Pta N-terminal part have no effects 
on regulation and catalytic activity [128]. Therefore, the function of the DRTGG 
domain remains largely unknown at present. 
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2 Aims of the Study 
This work was part of a larger project focusing on the catalytic mechanism and 
regulation of soluble PPases. The specific aims of my Ph.D. thesis were as follows:  
1. Crystallization of wild-type and variant S. cerevisiae PPases for determining the 
structures of missing intermediates in the reaction mechanism with its natural 
metal cofactor, magnesium (paper I). 
2. Production, crystallizing and solving structures of the regulatory region of 
Clostridium perfringens CBS-PPase with activating and inhibitory ligands to 
elucidate its mechanism of regulation by nucleotides (paper III).  
3. Cloning, expression, purification and mutagenesis of Moorella thermoacetica 






Detailed descriptions of the materials and methods employed are presented in the 
original publications I-IV. 
3.1 Cloning, mutagenesis, protein expression and 
purification (II-IV) 
Genomic DNA samples extracted from C. perfringens strain 13 and M. thermoacetica 
strain ATCC 35608 were obtained from German Collection of Microorganisms and 
Cell Cultures. Genes encoding C. perfringens CBS-PPase (cpCBS-PPase, GenBank 
NP_562971, Swiss-Prot Q8XIQ9) and M. thermoacetica CBS-PPase (mtCBS-PPase, 
GenBank NC_007644, Swiss-Prot Q2RFU3), as well as the regulatory region of 
cpCBS-PPase (residues 66-306, cpCBS) were amplified with PCR. NdeI-XhoI 
fragments were ligated into pET36+ plasmid transformed into the E. coli expression 
strain BL21-CodonPlus(DE3)-RIL (Stratagene). The NdeI-XhoI fragment of cpCBS 
was additionally ligated into the pET15b+ plasmid. For mutagenesis purposes, the 
XbaI-XhoI fragment of mtCBS-PPase was moved to pBLUESCRIPT SK- plasmid, and 
point mutations generated with the QuikChange kit (Stratagene).  
All CBS-PPase proteins were expressed in Terrific Broth (TB) medium, except the 
selenomethionyl derivative (SeMet), which was produced in B834(DE3) E. coli strain 
(Novagen) grown in commercial SelenoMet Medium Base with Nutrient Mix 
(Molecular Dimensions Ltd). Protein expression in TB medium was induced with 0.4 
mM isopropyl β-thiogalactopyranoside at A600 of 1.2, and cultures incubated for a 
further 3 h. Full-length proteins were purified with ionic exchange and size exclusion 
chromatography. To achieve higher purity for crystallization purposes, a histidine-
affinity tag was added. cpCBS was expressed with both the C-terminal His8 tag and N-
terminal thrombin cleavable His6-tag. His-tagged proteins were purified using 
immobilized-metal affinity and size exclusion chromatography. Thrombin digestion 
was performed overnight at room temperature using the affinity column. Concentrated 
proteins were stored at -70C. Protein purity was assessed with SDS-PAGE and 
homogeneity with native PAGE. Protein concentrations were estimated from their A280 
values.  
3.2 Characterization of proteins (II-IV) 
(II-IV) After optimization of reaction conditions, enzyme activity measurements were 
mainly performed at 25°C in 25-40 ml of 100 mM MOPS/KOH buffer (pH 7.2), 
including 0.1 mM CoCl2, 5 mM MgCl2 and 0.16 mM PPi for mtCBS-PPase or 0.1 mM 
CoCl2, 20 mM MgCl2 and 0.23 mM PPi for cpCBS-PPase. Reactions were initiated 
either by adding enzyme or PPi. Pi formation was monitored using a continuous Pi 
analyzer. Due to low mtCBS-PPase activity, a more sensitive method was used, and 




 (II & III) The oligomeric states of proteins with and without ligands and at 
different protein concentrations were determined via analytical ultracentrifugation on a 
Spinco E instrument (Beckman Instruments). Glutaraldehyde cross-linking 
experiments were conducted in parallel to support sedimentation analysis data. 
 (III) Thermostability measurements were performed using a differential scanning 
fluorometer (ThermoFluor) with the MiniOpticon Real-Time PCR System (BioRad). 
The assay mixture was placed in 96-well plates containing nucleotides at variable 
concentrations, full-length cpCBS-PPase, HEPES/KOH, pH 7.5, and SYPRO Orange 
(Invitrogen). Plates were heated from 30 to 99.9°C, and fluorescence monitored at 
523–543 nm.  
3.3 Crystallization and structure determination (I and III) 
Wild-type and variant scPPase proteins were stored at -20C in buffered 50% glycerol 
[38]. Glycerol was removed with buffer exchange before crystallization. CBS-PPases 
were stored at -70C without cryoprotectant. All proteins were crystallized with the 
vapor diffusion method, scPPases in sitting drops at 4C and CBS-PPases in hanging 
drops at room temperature. The scPPases contained 5 mM MgCl2 and 1 mM Pi as 
ligands in crystallization, whereas cpCBSs contained 0.15 mM AMP or 0.25 mM 
diadenosine tetraphosphate (AP4A) as regulators.  
Wild-type scPPase data were collected at synchrotron beam BM01 at ESRF 
(Grenoble, France) and all variant data collected with a Rigaku or Nonius generator 
and R-AXIS IV detector. All scPPases, including wild-type and the seven variants, 
crystallized to the P21 space group with almost identical unit cell parameters (a = 
51.58-51.92 Å, b = 93.00-93.55 Å, c = 69.17-70.11 Å and β = 99.33-100.01). 
Resolution was at least to 1.9 Å and optimally to 1.5 Å. Data were processed with 
Denzo [129]. Phases were from molecular replacement by using MOLREP [143] 
where the model structure was Mg2+-bound scPPase (PDB ID: 1HUK) [Swaminathan 
and others, unpublished]. Density fitting was performed with ARP/wARP [130], 
Refmac5 [131] used for refinement, and manual model building performed with O 
[132] and Coot [133]. Procheck was applied for structure validation [134]. 
All cpCBS data were collected at ESRF. Both types of cpCBS complexes 
crystallized to space group P212121 with similar unit cell parameters (AMP-bound, 
a = 58.96 Å, b = 79.61 Å, c = 116.36 Å; AP4A-bound, a = 63.85 Å, b = 71.76 Å, 
c = 116.33 Å). The complexes displayed slight differences in crystal packing (Figure 
8). We managed to crystallize His8-tagged cpCBS (with and without SeMet labeling) 
with AMP and His6 tag-removed protein with AP4A. Data were processed with XDS 
[135]. Both data sets were obtained to 2.3 Å resolution. Phasing appeared difficult due 
to pseudosymmetry. During processing, it was observed that every second spot was 
missing from axes a and c and therefore they had clear 21 screw axis, but b was not 
clear. According to Truncate [136] analysis, AMP-bound data appeared 




be due to the 2-fold non-crystallographic symmetry (NCS) axis parallel to the b-axis. 
For AP4A, the NCS axis was at an angle of 18.5 in relation to the b-axis (Figure 8). 
The L-test [137] (Table 2) in Xtriage [138] gave no indication of twinning. 
 
Figure 8. Different crystal packing structures of cpCBS. (a) Data for the AMP-bound structure 
are pseudosymmetric due to the parallel two-fold NCS axis (arrow) relative to unit cell b-axis. 
(b) In the AP4A-bound crystal structure, the NCS axis is rotated by 18.5, relative to the b-axis.  
Table 2. Pattersson and L-test analysis 
 AMP SeMet AMP AP4A 
Pattersson peak 0.500, 0.500, 0.224 0.500, 0.500, 0.222  
    % of origin 40 45  
Mean |L| 1 0.457 0.469 0.483 
Mean L2  2 0.288 0.300 0.314 
    Twin fraction 0.04 0.03 0.01 
        1 for twinned 0.375, untwined 0.500  
2 for twinned 0.200, untwined 0.333 
 
Phasing of pseudosymmetric data was difficult manually. After testing different 
methods, we used a combination of XDS and Auto-Rickshaw pipeline [139] to solve 
the phases of pseudosymmetric data. Used method was the MRSAD [140] where 




replacement. ShelxD [141] was effective in locating 8 selenium atoms out of a total of 
18. The figure of merit was 0.589 after refinement with MLPHARE [142], and density 
modification with DM [143] and ARP/wARP [130] allowed building of only 130 
residues into the electron density map. This model and phases were improved by 
feeding the resulting model back into Auto-Rickshaw using the MRSAD method 
together with the sequence. In combination with manual model building, this helped 
ARP/wARP to build 90% of the residues. The AP4A structure was solved by molecular 
replacement using MOLREP [144] using the AMP structure as a template. Structures 
were refined with REFMAC5 [131] through the CCP4 interface [145]. Manual model 
building was performed with Coot [133]. Coot and MolProbity [146] were used for 
structure validation. TLS refinement [147] lowered R-factors and helped to maintain 
reasonable geometry. 
3.4 Homology modeling  
For modeling of full-length cpCBS-PPase, we used structures of common family II 
PPases (PDB ID: 1K20, 1WPP, 2EBO, and 2HAW) and cpCBS complexes with AMP 
and AP4A as templates. Alignments were performed with Bodil [148]. 2D structures 
for the linker areas 65–73 and 296–307 were predicted with PSIPRED [149, 150], and 
homology modeling performed with Modeller 9v6 [151]. PSIPRED predicted that the 
linker region between positions 66 and 72 forms an α-helix. The linker region 
(positions 296–307) was disordered in our structures, and prediction did not provide a 
reliable structure. However, we modeled residues 296–305 as an α-helix, based on 
other CBS domain structures. 
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4 Results and Discussion 
4.1 Complete catalytic cycle of family I PPases (I) 
In paper I, wild-type and seven variant scPPases (Table 3) were crystallized with 
phosphate and the physiological metal cation, Mg2+, whereas previous structures 
contained Mn2+ or Co2+, which allowed efficient structure determination due to 
anomalous signals. Interestingly, all Mg2+-bound crystals displayed one monomer in an 
open form (A) and the other in a closed conformation (B) due to crystal packing. The 
loop of residues 103−115 was ordered in the closed form, but disordered in the open 
form. Seven conservative point mutants of residues around the electrophilic 
phosphorus, P2, and at the bottom of the active site were generated, including E48D, 
Y93F, D115E, D117E, D120E, D120N and D152E (Figure 2 in original publication I). 
The active site conformations depended on the PPase variant, and were structurally 
equivalent to various intermediates along the reaction pathway.  
Most of the structures were very similar to that of wild-type at the backbone level, 
where overall rmsd between the structures was from 0.1 Å to 0.28 Å for 218−263 
superimposed Cα atoms. A monomers have more differences than B monomers, which 
adopt the same conformation as wild-type, except the closed monomer of the D152E 
mutant in which the active site is more disordered. Structures were determined to 1.5-
1.9 Å resolution, and the electron density maps allowed Mg2+ ions to be identified 
based on their geometry. Each active site contains one to four Mg2+ ions and zero to 
two phosphate ions (Table 3) depending on the mutation, and possibly, exact soaking 
time. In two open conformation structures (wt and D152E), the leaving phosphate 
(Pexit) exists on the “edge of cup” (Figure 1). One extra Mg
2+ (Mg9) is located nearby 
in the closed form of D152E. These structures may be assigned to several intermediates 
of the different reaction steps. 
Table 3. Active site content of Mg2+-complexed scPPases. (modified from paper I)  
 monomer A active site ligands monomer B active site ligands 
wta  Mg1, Mg2, Pexit Mg1, Mg2, Mg3, P1 
E48D Mg1, Mg3, P1 Mg1, Mg3, P1 
Y93F Mg1, Mg2 Mg1 
D115E Mg1, Mg2, Mg3, Mg4, P1, P2 Mg1, Mg2, Mg3, Mg4, P1, P2 
D117E Mg1, Mg2 Mg1, Mg2, Mg4, P2 
D120E Mg1, Mg3, P1   Mg1, Mg3, P1b
D120N Mg1, Mg3, P1 Mg1, P1 
D152E Mg2, Pexit Mg2, Mg9 
a wild-type, b Likely, two conformations 
 
PPases catalyze the hydrolysis of pyrophosphate, and require three to four divalent 
metal cations, depending on pH. The magnesium ion confers highest catalytic activity. 
Together with previously reported structures, the solved scPPase structures provide the 
first complete structural description of the catalytic cycle. The mutations affected metal 
binding and the hydrogen bonding network in the active site, providing an insight into 
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the roles of specific residues. Analysis of the wild-type and four variant proteins 
provided information on the different reaction intermediates. Based on the new 
structures, the reaction mechanism scheme was revised (Figure 9a) to include two 





Figure 9. (a) Revised reaction scheme and (b) active site structures. Residues R78, Y93, D117, 
D120, Y192, and K193 are labeled in intermediate A. Metals, phosphates, and the two water 
molecules bridging M1 and M2 are further shown. PDB IDs for intermediates: A, 1WGI [19]; 
B, D115EA with PPi modeled; C, 1E6A [29]; D, 1E9G [27] conformation B(1); E, 1E9G 
conformation A(1); E‘, D115EA; F, wtB; F‘, E48DA (paper I). 
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Several structures are involved in step A, including monomer A of wild-type, Y93F 
and D117E (Figure 9b) encompassing both Mg1 and Mg2 with two water molecules in 
between. Similar structure and composition were previously observed with Mn2+ ions 
(PDB ID: 1WGI [19]). The structure of the substrate-bound enzyme before nucleophile 
attack (intermediate B) was not solved, but modeled for D115EA by inserting PPi in the 
place of two Pis. The situation after reorganization (state C) is presented for the 
D117EB structure, even though P1 and Mg3 are missing due to mutation. Furthermore, 
the active site is fully occupied in the fluoride-inhibited Mn2+ structure (PDB ID: 1E6A 
[27]). State D is represented by the high-resolution Mn2+ structure (PDB ID: 1E9G 
[27]). All four product-releasing intermediates are represented as Mg-bound variant 
structures, specifically, state E in the D115EB structure where one water molecule 
binds and weakens P1 interactions, state E’ in D115EA (also PDB ID: 117E [29] and 
1E9G [27]) where another water molecule is added, and alternative state F in E48DB as 
well as wtB where the Mg3-P1 complex is released before the addition of a second 
water molecule (step leading to F’) in E48DA. Determination of these structures 
completes the X-ray structural studies by providing all kinetically recognized reaction 
intermediates, including two alternative product release and nucleophile regeneration 
pathways that cannot be distinguished based on kinetic data and possibly operate in 
parallel.  
4.2 Production and initial characterization of CBS-PPases (II 
and III) 
We have cloned, expressed, purified and characterized full-length CBS-PPase from 
Clostridium perfringens and the enzyme from Moorella thermoacetica, one of three 
known CBS-PPases without the DRTGG domain. Several other CBS-PPases cloned 
were less amenable to purification than cpCBS-PPase. The solubility of this protein 
was approximately 15 mg/ml. The protein did not move as a sharp band on native 
PAGE (data not shown). Shorter mtCBS-PPase was easier to handle, as it could be 
concentrated to 100 mg/ml, and migrated as a sharp band on native PAGE, although 
the purity assessed using SDS-PAGE was not as good as that for single-banded 
cpCBS-PPase (data not shown).  
The cpCBS-PPase activity was very low in the presence of Mn2+ and Mg2+. Trials 
with different metals showed that Co2+ and Ni2+ (unpublished result) are the best 
cofactors for both CBS-PPases. Magnesium was also needed for optimal catalytic 
activity, and thus, subsequent studies employed both Co2+ and Mg2+. This Co2+ / Ni2+ 
preference was an interesting finding, as both these metals are essential trace elements 
for Moorella thermoacetica [152].  
The catalytic constant, kcat, appeared quite low for CBS-PPases, specifically, 1.7 s
-1 
for mtCBS-PPase and 20 s-1 for cpCBS-PPase, which is over 100 times lower than that 
for common family II PPases. CBS domains may thus play an autoinhibitory role in 
CBS-PPases. 
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Furthermore, CBS-PPases were found to be regulated by nucleotides. Nucleotide 
specificity was estimated using mtCBS-PPase. Adenosine compounds induced the 
most significant effects. ATP activated, while ADP and AMP inhibited CBS-PPases 
(II). The nucleotides were effective at nanomolar (ADP) or micromolar (AMP and 
ATP) concentrations, representing 100–10,000-fold stronger binding than that in other 
CBS domain-containing proteins [105, 115, 124]. The two CBS-PPases investigated 
had different nucleotide specificities. AMP was the strongest inhibitor, and diadenosine 
tetraphosphate (AP4A) activated cpCBS-PPase 2.5-fold (III). 
4.3 Overall structure of CBS-PPase (III) 
Extensive crystallization trials were performed with both full-length CBS-PPases. 
Small, straight needles were obtained once with cpCBS-PPase, but these were too 
small for structural studies and could not be reproduced. The best mtCBS-PPase 
crystals obtained diffracted to 4.5 Å, but optimization did not lead to improvements in 
crystal quality. Crystallization of these proteins, which contain several flexible 
domains and potential stabilizing ligands, appeared a significant challenge.  
Accordingly, a truncated version of cpCBS-PPase was constructed by deleting the 
catalytic region, keeping in mind that homologous structures are already available. We 
were thus able to crystallize and solve the structure of the regulatory part CBS1-
DRTGG-CBS2 (cpCBS). cpCBS-His8 was crystallized with AMP, and cpCBS with the 
His-tag removed (via thrombin cleavage) with AP4A. For phasing purposes, the 
cpCBS-His8-AMP complex was crystallized with SeMet protein.  
The CBS domain fold in cpCBS structures was similar to those of other CBS 
domain structures whereby the core topology forms a β-α-β-β-α assembly (Figure 4, 
10), but the last helix of the CBS2 domain was disordered. A unique feature of our 
structures is the presence of the DRTGG domain insert between the CBS domains, in 
contrast to the successive CBS domains in all other structures.  
The CBS1 and DRTGG domains are mainly well-ordered in the cpCBS structures, 
while the CBS2 domain appears more flexible, in view of its higher B-factor values. 
The two monomers in the asymmetric unit are similar in both structures, where rmsd 
per Cα is below 0.6 Å. The only significant difference is in the CBS1-DRTGG linker, 
whereby monomers adopt different conformations in the activator structure due to 
crystal contacts and the same areas are disordered in the inhibitor structure. Both 
structures display one special feature. Tyr124, located at the NCS axis, adopts two 
conformations within a very confined space by forming hydrogen bonds either with the 
carbonyl oxygen of Arg240 or, in unusual manner, with Met125 [153]. While the 
refinement was somewhat complicated due to translational pseudosymmetry in the 
inhibitor complex, the ligand-binding site is well-ordered in both structures. 




Figure 10. The overall structure of dimeric cpCBS-His8 complexed with AMP. The CBS1 core 
is presented in yellow, the DRTGG domain is in blue, and the CBS2 domain is in green, while 
linker areas are shown in gray. The second subunit is presented in similar, but lighter colors. 
AMP is depicted in red. The CBS domain core topology, β1–α1–β2–β3–α2, is indicated in 
CBS1′. (paper III) 
cpCBS forms a homodimer (Figure 10) in which all three domains interact with the 
adjacent identical domains of the other monomer. The dimeric structure of soluble 
cpCBS has been confirmed with sedimentation and cross-linking experiments (III). 
Full-length mtCBS-PPase (II) is also homodimeric, similar to common family II 
PPases [154]. CBS-PPases appear to be tighter dimers, since dissociation is not 
observed at low enzyme concentrations, in contrast to common family II PPases [54].  
4.4 Ligand binding to CBS domains 
4.4.1 Adenylate binding to cpCBS-PPase (III) 
The cpCBS crystals grown in the presence of AMP contained two AMP molecules 
bound per dimer (i.e., one AMP per CBS pair). The nucleotide was clearly visible in 
the difference map between the CBS1 and CBS2 domains on the side of CBS1 (Figure 
11a). The adenine moiety forms hydrophobic interactions with Met114 of CBS1 and 
Tyr278 of CBS2, as well as hydrogen bonds with the main-chain atoms of CBS2 
Asn280 and Val258 in the linker region before the CBS2 domain core. Ribose 
hydroxyls form hydrogen bonds with Asn119 and Thr253 in linker before the CBS2 
core. Phosphate is coordinated to Ser116 and Ser118 hydroxyls and Lys100′ (the 
primed number refers to the symmetry-related residue from the other subunit of the 
dimer). A water molecule bound to Ser101 and Asn280 forms hydrogen bonds with 
both adenine N7 and phosphate. 




Figure 11. Positive difference maps (contoured at 3.0 σ) of bound AMP (a) and AP4A (b). The 
lower subunits in (a) and (b) are shown in detail, with residue numbers. Monomer A is shown in 
green and monomer B in blue. Red balls refer to water molecules. CBS1 motif residues are 
from Met114 to Asn 119. (paper III) 
In cpCBS crystals grown in the presence of AP4A, only one ligand molecule is 
present (Figure 11b), which occupies two binding sites, which are same as for AMP. 
While AP4A adenine interactions are similar to those in the AMP-bound structure, 
ribose and phosphate interactions are clearly different. Asn119 and Thr253, which 
form hydrogen bonds with ribose in the AMP structure, interact with the activator only 
via a water molecule. Instead, ribose is hydrogen-bonded to Ser116 and Ser118 in the 
cpCBS–AP4A complex. Two phosphates of AP4A bind to Ser279 and Lys100′. In 
contrast, the contacts between AMP and the CBS2 domain are similar to those in the 
AP4A-bound structure. 
4.4.2 Comparison with other CBS domain proteins  
Binding of AMP by the CBS domain pair is similar, but not identical to that reported 
previously for other CBS proteins [73, 109, 111-113]. The adenine ring is invariably 
bound by two hydrophobic residues, which are aligned with Met114 and Tyr278 of 
cpCBS, and via two main chain interactions (Figure 11). Asn119 in CBS1 motif 
interacting with the ribose moiety in cpCBS is Asp in all AMP-bound structures. The 
second ribose-binding residue, Thr in cpCBS and Ser in the CBS domain-containing 
protein from Sulfolobus solfataricus (PDB ID: 3DDJ), is Arg in AMP-activated protein 
kinase [112], Asp in possible d-arabinose 5-phosphate isomerase yrbH from E. coli 
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(PDB ID: 3FNA), and Asn in the CBS domain protein PAE2072 from Pyrobaculum 
aerophilum (PDB ID: 2RIF). The highest variability is observed in the phosphate-
binding residues. Ser116 and Ser118 are nearly always aligned with Ser or Thr in other 
proteins (Ser118 is replaced with Arg in the PAE2072 protein from P. aerophilum) and 
the residue corresponding to Lys100 is typically replaced with non-aligning Lys, His or 
Ser in other structures. 
4.5 Proposed mechanism of cpCBS-PPase regulation (III) 
The overall structures of the two cpCBS complexes superimpose with an rmsd of 1.32 Å 
for all equivalent residues (460 Cα atoms). CBS2 domain movement is responsible for 
this deviation. The CBS2 domains, including the linker before the CBS1 core (99 Cα 
atoms), superimpose with rmsd of 2.32 Å, whereas the rmsd value is only 0.71 Å for the 
rest of the structure (362 Cα atoms). A clear conformational transition is evident from the 
inhibitor- to activator-bound form, where different orientations of the adenosine rings of 
the activator lead to displacement of Tyr278 and the whole RY278SN loop, and 
consequently, a more open CBS2 domain dimer interface (Figure 12). 
 
Figure 12. Stereo view of the superimposed AMP- (blue) and AP4A-bound (red) CBS pair 
structures of cpCBS representing movement of Tyr278 along aromatic interactions to the 
adenine ring of ligand (1), conformational changes of the RY278SN loop (2), and opening of the 
CBS2 dimer interface in the AP4A complex (3). (paper III) 
Ligand-induced conformational changes in CBS domains were confirmed by 
comparing the effects of the inhibitor and activator on the thermostability of full-length 
cpCBS-PPase (Figure 13). The melting point of AMP-bound enzyme was 7C higher and 
that of the AP4A-bound form was 10C lower, compared with the ligand-free enzyme.  




Figure 13. ThermoFluor measurement of cpCBS-PPase thermostability in the presence of AMP 
and AP4A. 
The available structures of several ligand complexes of MJ0100 demonstrate 
remarkable movement [67]. A comparison of ligand-induced cpCBS structure opening 
with that of MJ0100 revealed the most marked movement in the CBS2 domain 
interface in both proteins. Interestingly, similar displacement of a phenylalanine 
residue from the dimer interface to its own CBS domain interior was observed in 
activated cpCBS-PPase and 12- and 23-opened MJ0100.  
To obtain an insight into the pathway of the regulation signal to the enzyme active 
site, full-length cpCBS-PPase was modeled based on known common family II PPases 
and cpCBS insert structures (Figure 14). According to this model, the enzyme active 
sites are located 25 Å from the nucleotide-binding sites. Two possible mechanisms are 
envisaged. One assumes that the conformational change in the CBS domains allows 
more freedom of movement for the DHHA2 domain. DHHA2 domains are in close 
proximity to the moving CBS2 domain interface, and are expected to move during 
substrate binding and product release [48, 50]. Notably, the active site is formed by 
residues from DHH and DHHA2 domains connected by a flexible linker sequence. We 
speculate that in the AMP-inhibited state, the closed CBS2 domain interface prevents 
this movement and DHHA2 domains move freely in the open activated state.  
The other mechanism assumes that the insert causes disorder in the active site via 
direct effects on important residues. The basis for this mechanism is the finding that 
short linkers between DHH and CBS domains (residues 66–70 and 305–308) are 
adjacent to the DHH domain chain segment (residues 315–331), which connects two 
highly conserved active site motifs, DHNE314 and DHH334. A combination of these two 
mechanisms is additionally possible. 




Figure 14. (a and b) Two views of the modeled cpCBS-PPase domains complexed with AMP. 
In one subunit, the main PPase domains are shown in yellow (DHH) and red (DHHA2), CBS1 
and CBS2 domains presented in cyan and blue, respectively, and the DRTGG domain in 
orange. The other subunit is depicted in gray. Active sites are within black circles and regulator 
binding sites within the yellow circle. In (b), the molecule is rotated by 90°. The DHHA2 
domain is located on the flexible CBS2 domain interface (black bar). (paper III) 
4.6 The DRTGG domain (III) 
Our group initially described the DRTGG domain, which is present in many proteins. 
This domain is located between two CBS domains in CBS-PPases, and has an α/β 
structure. Domain topology is α1-β1-β2-α2-β3-α3-β4-α4-β5-α5, where the β-strand 
direction in the sheet is depicted with arrows in Figure 15. The conserved amino acids, 
D189R190 and T208G209G210 (numbered based on full-length cpCBS-PPase, Figure 16), 
are in close proximity on the domain surface, near the dimer interface, and located in 
loops after strands 3 and 4, respectively. The dimer contacts of the DRTGG domains 
are mainly formed by hydrophobic interactions of helices 5. The DRTGG domains are 
almost identical in both cpCBS structures (rmsd is 0.362 for all 220 C atoms in 
dimer), and contain no bound ligand. 




Figure 15. Topology of the DRTGG domain. (paper III) 
To date, the DRTGG domain structure of only one more protein, putative 
phosphotransacetylase (PtaN) from A. fulgidus (PDB ID: 2IOJ), has been determined. 
Its topology and overall structure are identical, with an rmsd of 1.88 for 90 C atoms. 
The greatest difference is in quaternary structure. Based on PISA [155], the crystal 
contacts of 2IOJ are not preserved in solution and the protein appears monomeric. A 
R252H mutation in 3 prevents NADH inhibition and enhances pyruvate activation of 
S. enterica phosphotransacetylase [127], but no binding of these effectors to the 
DRTGG domain has been demonstrated [128].  
The structures of two distant relatives of the DRTGG domain are available. The 
DRTGG domain belongs to the MurF_HprK_N clan (Pfam: PF07085), which also 
contains N-terminal domains of MurF (UDP-N-acetylmuramoyl-tripeptide D-Ala-D-
Ala ligase) and HPrK/P (histidine containing phosphor carrier protein 
kinase/phosphatase). The MurF N-terminal domain has the same -sheet topology as 
the DRTGG domain and binds inhibitors in two structures of MurF from Streptococcus 
pneumonia (PDB ID: 2AM1 and 2AM2) [156]. MurE from Mycobacterium 
tuberculosis (PDB ID: 2WTZ) is analogous to MurF, and binds  the UDP moiety of 
substrate in the same place [157]. An analogous area in cpCBS, located in the loop 
adjacent to the poorly ordered DR loop containing conserved A169 (Figure 16) may 
thus represent a potential binding site for an unrecognized ligand. Furthermore, the 
Staphylococcus xylosus HPrK/P structure (PDB ID: 1KO7) [158] contains two 
phosphate molecules bound at the dimer interface of Hpr_kinase_N domains, 
suggesting that a similar cavity found in cpCBS may also be a binding site for some 
ligand.  




Figure 16. The DRTGG domain of cpCBS is colored from blue (N-terminus) to red (C-
terminus). The other DRTGG monomer is depicted as a violet surface. The poorly ordered loop-
helix 2 region is gray. Conserved residues close to the subunit interface are presented as a ball-
and-stick model. The residues belonging to the conserved DR and TGG motifs are presented in 
green and yellow, respectively. The most conserved residues are underlined. (paper III) 
4.7 mtCBS-PPase variant analysis (IV)  
The effects of ligand binding were determined by mutating eight residues in potential 
regulatory ligand binding areas of mtCBS-PPase. The majority of residues were 
substituted with Ala or Gly, and Tyr169 was conservatively replaced with Phe. The 
residues for substitution were selected based on the mutations in the CBS domain-
containing proteins that cause human hereditary diseases; some of the most conserved 
and adjacent bulky residues were also mutated (Table 5). The disease-causing 
mutations (Figure 3), D444N in cystathionine β-synthase and R302Q in AMPK γ2, 
correspond to Lys100 of mtCBS-PPase. The L766P and R767Q/W mutations in ClC-7 
correspond to Tyr169 and Arg170 of mtCBS-PPase, respectively. R224P and D226N 
in IMPDH 1 correspond to mtCBS-PPase Arg187 and His189. Furthermore, R225W 
(corresponding to mtCBS-PPase Lys100) in human AMPK γ3 and V249I and R250G 
(corresponding to mtCBS-PPase Val99 and Lys100, respectively) in pAMPK γ3 trigger 
changes in the glycogen content of cells. Val99, Arg168, Tyr169, Arg170, and Arg187 
(mtCBS-PPase numbering) are highly conserved in CBS-PPases [159]. Furthermore, 
the cpCBS structure suggests that Tyr169 stacks with the adenine ring and Lys100 
binds phosphate. Residues at positions 168–170 form part of the RYRN sequence 
corresponding to the RYSN loop of cpCBS-PPase, which undergoes the most 
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significant conformational changes between the activator- and inhibitor-bound forms 
of the enzyme. Val99 of CBS2 is located at the same relative position as CBS1 Tyr169. 
Residues 187–189 of CBS2 include His189 corresponding to ribose-binding residues 
in the nucleotide-bound spAMPK [111] and ClC-5 [105] structures.  
Table 5. Conservation of mutated residues based on 116 CBS-PPase sequences (one sequence 
per species selected from UniProt [159]). 
Mutated residue* identity similarity variation within similar 
V99/99 25% 78% I/L/V/M/F 
K100/100 33% 48% K/R 
R168/277 64% 76% R/K 
Y169/278 33% 86% Y/F/H/V/L/I 
R170/279 84% 84% R/K 
R187/296 86% 91% R/K 
Y188/297 22% 24% Y/F 
H189/298 37%   
* Numbering based on mtCBS-PPase and cpCBS-PPase, respectively. 
 
Based on the effects of mutations on kcat,, variant enzymes were divided into three 
groups: 1) similar catalytic activity as wild-type (K100G), 2) more active (V99A, 
R168A, Y169A, Y169F, Y188A, and H189A), and 3) less active (R170A and R187G) 
enzymes.  
The majority of variant enzymes were inhibited by AMP, analogous to wild-type.  
Conversely, the R168A and Y169A variants were activated by AMP. The residual 
activity of the enzyme-AMP complex was increased in the Y188A and H189A 
variants. The AMP-binding affinity (Ki,app) was lowest for V99A, slightly decreased in 
K100G and Y188A, remarkably decreased in R168A and Y169A, not significantly 
affected in the Y169F and R170A variants, and notably elevated in the R187G and 
H189A mutant proteins (Table 6). In most cases, the effects on ADP affinity were 
parallel to those of AMP. Direct binding measurements with the membrane filtration 
assay disclosed that the stoichiometry of AMP binding increased from 1 to 2 ligands 
per monomer in the Y169F, R170A, R187G, and Y188A variants, implying occupancy 
of both CBS domains in the pair. Based on the mtCBS-PPase model, it is proposed that 
there is no space for two adenylate ligands in the wild-type CBS domain pair, but space 
may arise upon converting a bulky residue to the smaller Ala or Gly. 
Most substitutions appeared to enhanced enzyme activity by weakening 
autoinhibition, providing further support for the autoinhibitory role of CBS domains. 
Furthermore, we observed reversal of the AMP effect from inhibition to activation in 
the R168A and Y169A substituents. To our knowledge, no studies to date have 
reported changes in the direction of a nucleotide effect as a result of amino acid 
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The effects of substitutions on nucleotide binding affinity can be explained in terms 
of changes in nucleotide contacts (group 1 residues), whereas effects on activity may 
be attributable to alterations in the closure/opening of the CBS domain interface (group 
2 residues). Group 1 residues include Lys100, Tyr169 and Arg170. Group 2 residues, 
which do not interact with bound nucleotide in the cpCBS-PPase structure [8], include 
Arg168, Arg187 and Tyr188 located at the domain interface. R168 is present within 
the moving RYRN loop that probably plays a pivotal role in transmitting the regulatory 
signal to catalytic domains. Highly conserved R187 (Table 5) interacts with the RYRN 
loop and has different conformations in the two cpCBS structures. The Y188A 
substitution weakens dimer interface interactions, thereby favoring an open, activated 
conformation of the CBS domain pair. 
4.8 Possible physiological role of CBS-PPase regulation 
Constitutively active soluble PPases convert chemical energy to heat by hydrolyzing 
high-energy phosphate compounds. This is affordable during fast logarithmic growth 
when considerable energy is available and PPi hydrolysis favors biosynthetic reactions. 
At low energy and other stress conditions, this results in wasting energy unless PPase 
activity is suppressed. There is some evidence of family I and family II PPase 
inhibition upon phosphorylation [14, 58], but it is not known if phosphorylation occurs 
more widely within these families. The CBS domain pair is another type of down and 
up regulator of PPases. CBS-PPases respond to cell energy levels via down-regulation 
under low energy conditions (II and III). Notably, mtCBS-PPase is activated at high 
energy levels. Saved energy therefore becomes available for energy-consuming events 
in cells. 
According to the complete genome sequences in the KEGG  database [56], almost 
all organisms have at least one inorganic pyrophosphatase. All eukaryotic organisms 
only contain soluble family I PPases, except plants and protists, which additionally 
contain membrane-bound PPase. The only known exception is the eukaryotic 
protozoan parasite Giardia lamblia, which contains two CBS-PPases. Family I PPase 
is most common also in Archaea and Prokaryotes. Separate bacterial families usually 
have one type of soluble PPase, and occasionally, a membrane-bound PPase. There are, 
however, limited cases of different PPase composition in species within some genera. 
This finding is suggestive of horizontal gene transfer at some stage of evolution. 
A more comprehensive analysis of Bacteria indicates that many bacterial families, 
such as Beta-, Gamma- and Epsilonproteobacteria, mainly contain family I PPases, 
whereas others, like Firmicutes, contain family II PPases. The exception is the Vibrio 
genus, which contains both family I and II PPases [160]. CBS-PPases are thus found 
mainly in Firmicutes, and sporadically in other Bacteria and Archaea. One strict rule is 
that membrane-bound PPase never coexists with common family II PPase, but only 
with CBS-PPase or family I PPase. This finding suggests that membrane-bound PPase 
is a potential PPi user in cell stress, which is supported by the finding that 
overexpression of the membrane-bound enzyme in plants increases their drought  and 
salt tolerance [161, 162]. Indirect support also comes from the observation that 
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Fusobacterium nucleatum has both membrane-bound PPase and CBS-PPase, whereas 
all other Fusobacterium species (Leptotrichia buccalis, Sebaldella termitidis and 
Streptobacillus moniliformis) that have lost membrane PPase contain common family 





Structural studies on scPPase active site variants with the natural metal cofactor, Mg2+, 
have facilitated establishing of the complete reaction scheme in terms of the three-
dimensional structures of all eight reaction intermediates. Our data support two parallel 
routes for product release. With this complete structural scheme, the soluble family I 
PPase has become one of the most well-characterized phosphoryl transfer enzymes.  
This study mainly focused on a recently discovered subfamily of family II PPase, 
CBS-PPase. Our results provide support for the theory that the CBS domain insert acts 
as an autoinhibitor of the enzyme. Furthermore, mtCBS-PPase is inhibited by AMP 
and ADP and activated by ATP, i.e., it works as an energy state sensor, thereby 
regulating biosynthetic reactions via changing the concentration of the inhibitor, PPi. 
Effective adenine nucleotide concentrations are nanomolar or micromolar, which are 
significantly stronger than that previously reported for CBS domain proteins. 
We have presented direct evidence that cpCBS-PPase binds the unique activator, 
AP4A, which is a novel ligand for CBS domains. AP4A is accumulated during heat 
shock and oxidative stress. Hypothetically, the enzyme may play a role in gas gangrene 
caused by C. perfringens, and thus act as a potential target for drug development. 
The structural mechanism of CBS-PPase activation by AP4A and inhibition by 
AMP was addressed by solving the structures of the regulatory part of cpCBS-PPase 
complexed with these nucleotides. We have shown that CBS-PPase forms a 
homodimer in which the CBS domain pairs and DRTGG domains dimerize face-to-
face, similar to the DHH domains in common family II PPase. Comparison of these 
structures has allowed the discovery of the most significant conformational changes 
associated with nucleotide binding to CBS domains for the first time. The major 
difference between the activator and inhibitor complexes is that the latter has a much 
less open CBS domain interface due to displacement of a RYRN loop and a Tyr 
residue.  
A homology model of full-length cpCBS-PPase was generated to provide an  
insight into the pathway of regulatory signal transmission from CBS domains to the 
catalytic part, which are located 25 Å apart. Two probable regulation mechanisms are 
suggested. One mechanism proposes that inhibitor-bound CBS domains arrest catalytic 
DHHA2 domain movement, while the other suggests a direct effect on active site 
residues by the regulatory part inserted within the other catalytic DHH domain. The 
two mechanisms may also act in parallel. 
Mutational and functional studies on mtCBS-PPase have led to the identification of 
several residues responsible for nucleotide binding to CBS domains, binding 
specificity and direction of subsequent effects on activity (activation or inhibition).  
Our group initially described the structure of the DRTGG domain, which is also 




dimerization. Further studies are required to elucidate its possible role in activity 
regulation.  
Genome sequence analyses have disclosed that membrane-bound PPases never 
occur together with highly active common family II PPases, but are common partners 
of CBS-PPases. This combination would permit CBS-PPase inhibition under stress 
conditions, allowing membrane-bound PPases to use PPi energy to drive proton and 
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